This statistic shows the market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015. In 2015, the Chinese anti-osteoporosis medicine Xian Ling Gu Bao had a market share of nearly 37 percent among public medical institutions in China.
Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shihuida Pharma Group, & MENET. (March 29, 2017). Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015 [Graph]. In Statista. Retrieved December 23, 2024, from https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/
Shihuida Pharma Group, und MENET. "Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015." Chart. March 29, 2017. Statista. Accessed December 23, 2024. https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/
Shihuida Pharma Group, MENET. (2017). Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015. Statista. Statista Inc.. Accessed: December 23, 2024. https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/
Shihuida Pharma Group, and MENET. "Market Share of Chinese Medicine Anti-osteoporosis Drugs in Chinese Public Medical Institutions in 2015." Statista, Statista Inc., 29 Mar 2017, https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/
Shihuida Pharma Group & MENET, Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015 Statista, https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/ (last visited December 23, 2024)
Market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015 [Graph], Shihuida Pharma Group, & MENET, March 29, 2017. [Online]. Available: https://www.statista.com/statistics/772187/china-leading-anti-osteoporosis-drugs-in-public-medical-institutions-by-market-share/
